Vaccine Access Socioeconomic Factors Vulnerable Populations Vaccine Hesitancy Inequality Immunization Vaccination Access Impact of Infections Racial Inequality Sickle Cell Disease Vaccine Scarcity Patient Care Insurance Coverage Preventive Health Measures Children's Health Community Health Initiatives Economic Barriers Medicaid Lower-Income Populations Obesity Epidemic Malnutrition Public Health Infrastructure Global Health Issues Global Health Equity Community Health Impact of Policy Changes Global Health PrEP Access Diagnostic Tools
The decision leaves 7.5 million beneficiaries without access to effective weight-loss medications, despite evidence of significant health and economic benefits.